Literature DB >> 19254714

Focus on molecules: interleukin-1: a master regulator of the corneal response to injury.

Steven E Wilson1, Andrew Esposito.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19254714      PMCID: PMC2768564          DOI: 10.1016/j.exer.2009.02.011

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


× No keyword cloud information.
  4 in total

Review 1.  The corneal wound healing response: cytokine-mediated interaction of the epithelium, stroma, and inflammatory cells.

Authors:  S E Wilson; R R Mohan; R R Mohan; R Ambrósio; J Hong; J Lee
Journal:  Prog Retin Eye Res       Date:  2001-09       Impact factor: 21.198

2.  Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea.

Authors:  W Michael Stapleton; Shyam S Chaurasia; Fabricio W Medeiros; Rajiv R Mohan; Sunilima Sinha; Steven E Wilson
Journal:  Exp Eye Res       Date:  2008-02-13       Impact factor: 3.467

3.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).

Authors:  Reza Dana
Journal:  Trans Am Ophthalmol Soc       Date:  2007

Review 4.  IL-1, IL-18, and IL-33 families of cytokines.

Authors:  William P Arend; Gaby Palmer; Cem Gabay
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

  4 in total
  14 in total

Review 1.  Corneal wound healing.

Authors:  Steven E Wilson
Journal:  Exp Eye Res       Date:  2020-06-15       Impact factor: 3.467

2.  The expression of matrix metalloproteinases and their inhibitors in corneal fibroblasts by alarmins from necrotic corneal epithelial cells.

Authors:  Akira Iwatake; Akira Murakami; Nobuyuki Ebihara
Journal:  Jpn J Ophthalmol       Date:  2017-11-01       Impact factor: 2.447

3.  Efficacy of topical blockade of interleukin-1 in experimental dry eye disease.

Authors:  Andre Okanobo; Sunil K Chauhan; Mohammad H Dastjerdi; Shilpa Kodati; Reza Dana
Journal:  Am J Ophthalmol       Date:  2012-04-26       Impact factor: 5.258

4.  The NLRP3 Activation in Infiltrating Macrophages Contributes to Corneal Fibrosis by Inducing TGF-β1 Expression in the Corneal Epithelium.

Authors:  Jing Xu; Peng Chen; Xiaoyu Luan; Xinying Yuan; Susu Wei; Yaxin Li; Chuanlong Guo; Xianggen Wu; Guohu Di
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

5.  Corneal myofibroblast viability: opposing effects of IL-1 and TGF beta1.

Authors:  Harmeet Kaur; Shyam S Chaurasia; Vandana Agrawal; Chikako Suto; Steven E Wilson
Journal:  Exp Eye Res       Date:  2009-03-12       Impact factor: 3.467

6.  Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial.

Authors:  Francisco Amparo; Mohammad H Dastjerdi; Andre Okanobo; Giulio Ferrari; Leila Smaga; Pedram Hamrah; Ula Jurkunas; Debra A Schaumberg; Reza Dana
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

7.  Fibroblastic and bone marrow-derived cellularity in the corneal stroma.

Authors:  Steven E Wilson; Lycia Pedral Sampaio; Thomas Michael Shiju; Rodrigo Carlos de Oliveira
Journal:  Exp Eye Res       Date:  2020-10-14       Impact factor: 3.467

8.  IκB kinase β regulates epithelium migration during corneal wound healing.

Authors:  Liang Chen; Qinghang Meng; Winston Kao; Ying Xia
Journal:  PLoS One       Date:  2011-01-17       Impact factor: 3.240

9.  Combined effects of interleukin-1β and cyclic stretching on metalloproteinase expression in corneal fibroblasts in vitro.

Authors:  Pengfei Feng; Xiaona Li; Weiyi Chen; Chengxing Liu; Shuo Rong; Xiaojun Wang; Genlai Du
Journal:  Biomed Eng Online       Date:  2016-06-10       Impact factor: 2.819

10.  Comparison of the Effects of Subconjunctival Injections of Bevacizumab and Interferon Alpha-2a on Corneal Angiogenesis in a Rat Model.

Authors:  Sinan Bilgin
Journal:  Medicina (Kaunas)       Date:  2018-04-16       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.